Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (NHPBP) Tax Provisions (2016 - 2025)

Historic Tax Provisions for National Healthcare Properties (NHPBP) over the last 12 years, with Q3 2025 value amounting to $66000.0.

  • National Healthcare Properties' Tax Provisions changed N/A to $66000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $187000.0, marking a year-over-year decrease of 360.82%. This contributed to the annual value of $262000.0 for FY2024, which is 1353.14% down from last year.
  • Per National Healthcare Properties' latest filing, its Tax Provisions stood at $66000.0 for Q3 2025.
  • In the past 5 years, National Healthcare Properties' Tax Provisions registered a high of $157000.0 during Q3 2023, and its lowest value of -$6000.0 during Q1 2025.
  • Moreover, its 5-year median value for Tax Provisions was $55000.0 (2021), whereas its average is $60529.4.
  • In the last 5 years, National Healthcare Properties' Tax Provisions skyrocketed by 11777.11% in 2021 and then tumbled by 10857.14% in 2025.
  • National Healthcare Properties' Tax Provisions (Quarter) stood at $41000.0 in 2021, then increased by 2.44% to $42000.0 in 2022, then surged by 40.48% to $59000.0 in 2023, then skyrocketed by 115.25% to $127000.0 in 2024, then plummeted by 48.03% to $66000.0 in 2025.
  • Its Tax Provisions was $66000.0 in Q3 2025, compared to -$6000.0 in Q1 2025 and $127000.0 in Q4 2024.